↓ Skip to main content

Indian vaccine innovation: the case of Shantha Biotechnics

Overview of attention for article published in Globalization and Health, April 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#10 of 1,236)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
25 news outlets
blogs
1 blog
policy
2 policy sources
twitter
107 X users
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
99 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Indian vaccine innovation: the case of Shantha Biotechnics
Published in
Globalization and Health, April 2011
DOI 10.1186/1744-8603-7-9
Pubmed ID
Authors

Justin Chakma, Hassan Masum, Kumar Perampaladas, Jennifer Heys, Peter A Singer

Abstract

Although the World Health Organization had recommended that every child be vaccinated for Hepatitis B by the early 1980s, large multinational pharmaceutical companies held monopolies on the recombinant Hepatitis B vaccine. At a price as high as USD$23 a dose, most Indians families could not afford vaccination. Shantha Biotechnics, a pioneering Indian biotechnology company founded in 1993, saw an unmet need domestically, and developed novel processes for manufacturing Hepatitis B vaccine to reduce prices to less than $1/dose. Further expansion enabled low-cost mass vaccination globally through organizations such as UNICEF. In 2009, Shantha sold over 120 million doses of vaccines. The company was recently acquired by Sanofi-Aventis at a valuation of USD$784 million.

X Demographics

X Demographics

The data shown below were collected from the profiles of 107 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 2%
Spain 1 1%
Portugal 1 1%
Unknown 95 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 18%
Student > Master 17 17%
Other 9 9%
Student > Bachelor 7 7%
Student > Ph. D. Student 7 7%
Other 15 15%
Unknown 26 26%
Readers by discipline Count As %
Medicine and Dentistry 16 16%
Social Sciences 13 13%
Economics, Econometrics and Finance 9 9%
Nursing and Health Professions 6 6%
Agricultural and Biological Sciences 5 5%
Other 21 21%
Unknown 29 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 292. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2022.
All research outputs
#121,080
of 25,582,611 outputs
Outputs from Globalization and Health
#10
of 1,236 outputs
Outputs of similar age
#339
of 120,453 outputs
Outputs of similar age from Globalization and Health
#1
of 12 outputs
Altmetric has tracked 25,582,611 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,236 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.